Clinical Context
A typical patient scenario involves a school-aged child or otherwise healthy adult presenting to a primary care clinic, community health center, or public health vaccination site during a pandemic influenza season to receive a live attenuated intranasal influenza vaccine. The clinical workflow begins with registration and verification of patient identity and insurance (Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, Medicare). A brief medical screening reviews contraindications (e.g., pregnancy, immunocompromise, severe egg allergy, recent antiviral use) and documents current medications and chronic conditions. Informed consent for vaccination is obtained, vaccine lot number and expiration are recorded, and the intranasal administration is performed by a qualified clinician (pediatrician, family medicine physician, nurse practitioner, or registered nurse). Post-administration observation for adverse reactions (typically 15 minutes for those with history of allergies) follows. Documentation includes CPT 90664 (intranasal live pandemic influenza vaccine), vaccine manufacturer, lot, route, dose, site of administration (intranasal), and any applicable modifier (for example SL when state-supplied vaccine is used). Billing and claim submission include the appropriate payer and taxonomy for the administering clinician, with coding for the vaccine and any related visit services if medically necessary.